Oracle (NYSE:ORCL) Stock Rating Reaffirmed as Overweight by Cantor Fitzgerald

Key Points

• Cantor Fitzgerald reaffirmed an “overweight” rating on Oracle with a $284 price target, implying nearly 120% upside from the prior close. Analysts overall maintain a “Moderate Buy” consensus with an average target of $249.52.
• Oracle’s latest quarterly results exceeded expectations, with adjusted EPS of $1.92 versus the $1.74 consensus and revenue of $19.35 billion. Revenue increased 29.6% year over year, supported by continued cloud and AI momentum.
• Despite growth opportunities, investors remain concerned about Oracle’s heavy AI infrastructure spending, deeply negative free cash flow, rising debt and potential credit-rating pressure. These funding and execution risks are weighing on the stock, which recently opened at $129.10.

Oracle (NYSE:ORCL - Get Free Report)'s stock had its "overweight" rating restated by stock analysts at Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They presently have a $284.00 price objective on the enterprise software provider's stock. Cantor Fitzgerald's target price would suggest a potential upside of 119.98% from the company's previous close.

Other equities analysts have also recently issued research reports about the stock. CLSA began coverage on shares of Oracle in a research report on Monday, July 20th. They issued a "hold" rating and a $145.00 price objective on the stock. JPMorgan Chase & Co. reissued a "buy" rating on shares of Oracle in a research note on Thursday, September 10th. Stifel Nicolaus cut their target price on Oracle from $220.00 to $200.00 and set a "buy" rating on the stock in a research note on Friday, September 11th. DZ Bank reissued a "buy" rating on shares of Oracle in a research note on Thursday, September 17th. Finally, Yorkville Ives began coverage on Oracle in a research note on Wednesday, October 7th. They issued an "in-line" rating and a $155.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, thirty-five have given a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $249.52.

Oracle Stock Down 1.6%

Shares of Oracle stock opened at $129.10 on Thursday. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.17 and a current ratio of 1.17. Oracle has a 52-week low of $114.50 and a 52-week high of $287.19. The company's 50 day moving average price is $144.17 and its 200-day moving average price is $158.44. The stock has a market capitalization of $390.36 billion, a price-to-earnings ratio of 20.24, a P/E/G ratio of 0.93 and a beta of 1.78.

Oracle (NYSE:ORCL - Get Free Report) last posted its quarterly earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 EPS for the quarter, beating analysts' consensus estimates of $1.74 by $0.18. Oracle had a net margin of 26.36% and a return on equity of 48.85%. The company had revenue of $19.35 billion during the quarter, compared to analyst estimates of $19.13 billion. During the same period in the prior year, the business posted $1.47 EPS. The firm's revenue was up 29.6% compared to the same quarter last year. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. Equities research analysts forecast that Oracle will post 6.73 EPS for the current year.

Insider Activity at Oracle

In related news, EVP Maria Smith sold 2,631 shares of Oracle stock in a transaction dated Tuesday, September 22nd. The shares were sold at an average price of $151.70, for a total transaction of $399,122.70. Following the completion of the transaction, the executive vice president directly owned 64,357 shares of the company's stock, valued at $9,762,956.90. This trade represents a 3.93% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Stephen H. Rusckowski purchased 25,000 shares of the stock in a transaction that occurred on Tuesday, September 29th. The shares were acquired at an average cost of $139.35 per share, with a total value of $3,483,750.00. Following the completion of the transaction, the director owned 25,390 shares in the company, valued at $3,538,096.50. This trade represents a 6,410.26% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders sold a total of 36,075 shares of company stock valued at $5,342,123 in the last three months. Company insiders own 38.40% of the company's stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of ORCL. North Point Portfolio Managers Corp OH purchased a new position in Oracle during the 3rd quarter valued at about $27,000. Maseco LLP bought a new stake in Oracle in the first quarter worth $29,000. Persistent Asset Partners Ltd bought a new stake in Oracle in the second quarter worth $29,000. Strengthening Families & Communities LLC boosted its holdings in Oracle by 231.3% in the third quarter. Strengthening Families & Communities LLC now owns 222 shares of the enterprise software provider's stock worth $30,000 after acquiring an additional 155 shares in the last quarter. Finally, Markowski Investments bought a new stake in Oracle in the second quarter worth $32,000. 42.44% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle’s AI and cloud strategy continues to generate commercial momentum. The company launched Fusion Claw agentic HR applications and AI Agent Studio for industry-specific workflows, potentially increasing the value of its Fusion Cloud platform and supporting enterprise demand. Oracle Introduces Claw-Powered Fusion Agentic Applications for HR
• Positive Sentiment: AstraZeneca is working with Oracle on AI tools to identify clinical-trial candidates and connect research data with healthcare workflows. The partnership expands Oracle’s healthcare opportunity and provides a high-profile validation of its AI capabilities, although the agreement is not expected to create material near-term revenue. Oracle Expands Its AI Healthcare Push With a New Drugmaker Partnership
• Positive Sentiment: TD Cowen suggested Nvidia may be helping Oracle finance or otherwise support its AI data-center build-out. Separately, a proposed push for data centers to generate their own electricity could help address power constraints and enable additional capacity, though it may also increase Oracle’s capital requirements. Nvidia May Be Helping Finance Oracle’s AI Data Centers
• Neutral Sentiment: Analysts and investors remain divided: Bank of America sees substantial upside from Oracle’s growth, while comparisons with Microsoft highlight Oracle’s faster cloud expansion but weaker free-cash-flow profile and heavier debt burden. Oracle’s multicloud database growth is another potentially important long-term catalyst.
• Negative Sentiment: The main pressure point is funding. Oracle’s cloud backlog reportedly exceeds $664 billion, but free cash flow is deeply negative as it accelerates AI infrastructure spending. Concerns that borrowing could threaten Oracle’s credit rating—and potentially lead to bond downgrades—are weighing on the stock. Oracle’s Growth to Valuation Mismatch is Less and Less Compelling
• Negative Sentiment: Reports that Oracle may face broader obligations related to human-resources AI agents, combined with concerns over delays and a force-majeure claim involving its large New Mexico data-center project, have reinforced worries about execution, costs, and customer commitments. Oracle Stocks Fall as HR Agents Broaden the RPO Burden

Oracle Company Profile

Oracle Corporation NYSE: ORCL is a global technology company that develops enterprise software, cloud infrastructure and database technologies. Its products help organizations store, manage, analyze and secure data, while supporting business operations across industries and geographies.

The company's offerings include Oracle Database, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud-based applications. These applications serve functions such as enterprise resource planning, financial management, human resources, supply-chain management, customer experience and industry-specific operations.